Year |
Citation |
Score |
2018 |
Qiu L, Patterson SE, Bonnac LF, Geraghty RJ. Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis. Plos Neglected Tropical Diseases. 12: e0006421. PMID 29672522 DOI: 10.1371/Journal.Pntd.0006421 |
0.527 |
|
2016 |
Rawson JM, Roth ME, Xie J, Daly MB, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase. Bioorganic & Medicinal Chemistry. PMID 27117260 DOI: 10.1016/J.Bmc.2016.03.052 |
0.633 |
|
2016 |
Daly MB, Roth ME, Bonnac L, Maldonado JO, Xie J, Clouser CL, Patterson SE, Kim B, Mansky LM. Dual anti-HIV mechanism of clofarabine. Retrovirology. 13: 20. PMID 27009333 DOI: 10.1186/S12977-016-0254-0 |
0.595 |
|
2016 |
Rawson JM, Daly MB, Xie J, Clouser CL, Landman SR, Reilly CS, Bonnac L, Kim B, Patterson SE, Mansky LM. 5-azacytidine enhances the mutagenesis of HIV-1 by reduction to 5-aza-2'-deoxycytidine. Antimicrobial Agents and Chemotherapy. PMID 26833151 DOI: 10.1128/Aac.03084-15 |
0.602 |
|
2015 |
Rawson JM, Landman SR, Reilly CS, Bonnac L, Patterson SE, Mansky LM. Lack of Mutational Hot Spots during Decitabine-Mediated HIV-1 Mutagenesis. Antimicrobial Agents and Chemotherapy. 59: 6834-43. PMID 26282416 DOI: 10.1128/Aac.01644-15 |
0.593 |
|
2014 |
Dapp MJ, Bonnac L, Patterson SE, Mansky LM. Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1. Journal of Virology. 88: 354-63. PMID 24155391 DOI: 10.1128/Jvi.02444-13 |
0.596 |
|
2014 |
Clouser CL, Bonnac L, Mansky LM, Patterson SE. Characterization of permeability, stability and anti-HIV-1 activity of decitabine and gemcitabine divalerate prodrugs. Antiviral Chemistry & Chemotherapy. 23: 223-30. PMID 23994876 DOI: 10.3851/Imp2682 |
0.557 |
|
2013 |
Bonnac LF, Mansky LM, Patterson SE. Structure-activity relationships and design of viral mutagens and application to lethal mutagenesis. Journal of Medicinal Chemistry. 56: 9403-14. PMID 23914828 DOI: 10.1021/Jm400653J |
0.492 |
|
2009 |
Elphick LM, Lee SE, Child ES, Prasad A, Pignocchi C, Thibaudeau S, Anderson AA, Bonnac L, Gouverneur V, Mann DJ. A quantitative comparison of wild-type and gatekeeper mutant cdk2 for chemical genetic studies with ATP analogues. Chembiochem : a European Journal of Chemical Biology. 10: 1519-26. PMID 19437469 DOI: 10.1002/Cbic.200900052 |
0.3 |
|
2009 |
Lee SE, Elphick LM, Anderson AA, Bonnac L, Child ES, Mann DJ, Gouverneur V. Synthesis and reactivity of novel gamma-phosphate modified ATP analogues. Bioorganic & Medicinal Chemistry Letters. 19: 3804-7. PMID 19410453 DOI: 10.1016/J.Bmcl.2009.04.028 |
0.333 |
|
2007 |
Bonnac LF, Gao GY, Chen L, Patterson SE, Jayaram HN, Pankiewicz KW. Efficient synthesis of benzamide riboside, a potential anticancer agent. Nucleosides, Nucleotides & Nucleic Acids. 26: 1249-53. PMID 18066762 DOI: 10.1080/15257770701528222 |
0.501 |
|
2007 |
Chen L, Gao G, Felczak K, Bonnac L, Patterson SE, Wilson D, Bennett EM, Jayaram HN, Hedstrom L, Pankiewicz KW. Probing binding requirements of type I and type II isoforms of inosine monophosphate dehydrogenase with adenine-modified nicotinamide adenine dinucleotide analogues. Journal of Medicinal Chemistry. 50: 5743-51. PMID 17958343 DOI: 10.1021/Jm070568J |
0.541 |
|
2007 |
Bonnac L, Gao GY, Chen L, Felczak K, Bennett EM, Xu H, Kim T, Liu N, Oh H, Tonge PJ, Pankiewicz KW. Synthesis of 4-phenoxybenzamide adenine dinucleotide as NAD analogue with inhibitory activity against enoyl-ACP reductase (InhA) of Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters. 17: 4588-91. PMID 17560106 DOI: 10.1016/J.Bmcl.2007.05.084 |
0.344 |
|
2007 |
Chen L, Gao G, Bonnac L, Wilson DJ, Bennett EM, Jayaram HN, Pankiewicz KW. Methylenebis(sulfonamide) linked nicotinamide adenine dinucleotide analogue as an inosine monophosphate dehydrogenase inhibitor. Bioorganic & Medicinal Chemistry Letters. 17: 3152-5. PMID 17395461 DOI: 10.1016/J.Bmcl.2007.03.035 |
0.333 |
|
2007 |
Suk DH, Bonnac L, Dykstra CC, Pankiewicz KW, Patterson SE. Rational design and synthesis of novel nucleotide anti-Giardia agents. Bioorganic & Medicinal Chemistry Letters. 17: 2064-7. PMID 17258459 DOI: 10.1016/J.Bmcl.2007.01.014 |
0.543 |
|
2007 |
Bonnac L, Chen L, Pathak R, Gao G, Ming Q, Bennett E, Felczak K, Kullberg M, Patterson SE, Mazzola F, Magni G, Pankiewicz KW. Probing binding requirements of NAD kinase with modified substrate (NAD) analogues. Bioorganic & Medicinal Chemistry Letters. 17: 1512-5. PMID 17258457 DOI: 10.1016/J.Bmcl.2007.01.012 |
0.567 |
|
2006 |
Chen L, Rejman D, Bonnac L, Pankiewicz KW, Patterson SE. Nucleoside-5'-phosphoimidazolides: reagents for facile synthesis of dinucleoside pyrophosphates. Current Protocols in Nucleic Acid Chemistry / Edited by Serge L. Beaucage ... [Et Al.]. Unit 13.4. PMID 18428947 DOI: 10.1002/0471142700.Nc1304S23 |
0.562 |
|
2004 |
Bonnac L, Innocenti A, Winum JY, Casini A, Montero JL, Scozzafava A, Barragan V, Supuran CT. Carbonic anhydrase inhibitors: aliphatic N-phosphorylated sulfamates--a novel zinc-anchoring group leading to nanomolar inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 19: 275-8. PMID 15500000 DOI: 10.1080/14756360410001689522 |
0.352 |
|
Show low-probability matches. |